AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 59(1), 1998, pp. 129-132
Copyright © 1998 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lobel, H.
Right arrow Articles by Barber, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lobel, H.
Right arrow Articles by Barber, A.
Related Collections
Right arrow Plasmodium
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 59, Issue 1, 129-132
Copyright © 1998 by American Society of Tropical Medicine and Hygiene

Research Articles


Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health

HO Lobel, JK Varma, M Miani, M Green, GD Todd, K Grady, and AM Barber

The effectiveness of mefloquine to prevent malaria caused by Plasmodium falciparum is influenced by the sensitivity of the malaria parasites to this drug. Concern has been raised that resistance to mefloquine may develop in sub-Saharan Africa as has been observed in Southeast Asia. Case reports, along with blood smears to confirm the diagnosis and blood samples to determine the mefloquine concentration, were provided on any Peace Corps volunteer serving in sub-Saharan Africa who was diagnosed with malaria. We defined prophylaxis failures probably due to mefloquine resistance as patients with P. falciparum malaria confirmed at the Centers for Disease Control and Prevention, reported compliance with prophylaxis, no ingestion of mefloquine between date of illness onset and date of blood drawing, and a mefloquine level > or = 620 ng/ml in blood drawn within five days of onset of illness. Between January 1, 1991 and September 6, 1996, 44 (31%) of 140 volunteers with confirmed P. falciparum had blood drawn within five days of onset of illness. Twenty-nine (66%) had not fully complied with prophylaxis. Five of 15 prophylaxis failures in four countries had mefloquine levels > or = 620 ng/ml. Failure of mefloquine prophylaxis is primarily due to noncompliance. Evidence of probable resistance to mefloquine among strains of P. falciparum was found in five Peace Corps volunteers in sub-Saharan Africa. Clusters of well-documented prophylaxis failures need to be followed-up by therapeutic in vivo studies to document parasite resistance to mefloquine. Reduced sensitivity to mefloquine does not (yet) appear to be a significant problem in sub-Saharan Africa.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
D. J. FRYAUFF, S. OWUSU-AGYEI, G. UTZ, J. K. BAIRD, K. A. KORAM, F. BINKA, F. NKRUMAH, and S. L. HOFFMAN
MEFLOQUINE TREATMENT FOR UNCOMPLICATED FALCIPARUM MALARIA IN YOUNG CHILDREN 6-24 MONTHS OF AGE IN NORTHERN GHANA
Am J Trop Med Hyg, February 1, 2007; 76(2): 224 - 231.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. K. Baird
Effectiveness of Antimalarial Drugs
N. Engl. J. Med., April 14, 2005; 352(15): 1565 - 1577.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
G. Dorsey, M. Gandhi, J. H. Oyugi, and P. J. Rosenthal
Difficulties in the Prevention, Diagnosis, and Treatment of Imported Malaria
Arch Intern Med, September 11, 2000; 160(16): 2505 - 2510.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society of Tropical Medicine and Hygiene.